Edition:
United States

miRagen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

5.86USD
15 Aug 2018
Change (% chg)

-- (--)
Prev Close
$5.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
43,928
52-wk High
$10.68
52-wk Low
$5.01

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.32 December 16 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 3 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 3 1.89 2.20 1.30 0.50
Quarter Ending Dec-18 3 2.04 3.18 1.23 0.50
Year Ending Dec-18 4 9.93 12.33 7.00 0.60
Year Ending Dec-19 4 5.46 10.73 0.00 0.92
Earnings (per share)
Quarter Ending Sep-18 4 -0.32 -0.26 -0.38 -0.37
Quarter Ending Dec-18 4 -0.33 -0.28 -0.38 -0.38
Year Ending Dec-18 4 -1.12 -1.01 -1.20 -1.87
Year Ending Dec-19 4 -1.58 -1.33 -2.00 -2.01

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.83 2.18 1.35 161.63
Quarter Ending Mar-18 1.17 4.78 3.61 307.84
Quarter Ending Dec-17 1.34 1.19 0.15 11.29
Quarter Ending Sep-17 0.31 1.63 1.33 433.01
Quarter Ending Jun-17 0.50 0.72 0.22 43.60

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1.89 0.87 0.87 0.87 0.50
Quarter Ending Dec-18 2.04 1.00 1.00 1.00 0.50
Year Ending Dec-18 9.93 6.82 6.82 6.82 0.60
Year Ending Dec-19 5.46 2.25 2.25 2.25 0.92

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 2 0 2 0
Quarter Ending Dec-18 3 0 3 0
Year Ending Dec-18 4 0 4 0
Year Ending Dec-19 2 0 2 0
Earnings